Nilanjan Sinha

Nilanjan Sinha, director with Quintiles Phase One Clinical Trials India Private Limited, is registered with the Ministry of Corporate Affairs (MCA), bearing DIN 07653553. He is an Indian staying in Bangalore, Karnataka, India.
Nilanjan Sinha is currently associated with 8 Companies and is director with Excel Life Sciences Private Limited, Ims Health Technology Solutions India Private Limited, Cenduit (India) Services Private Limited, Iqvia Rds (India) Private Limited, Clintec Cro Services (India) Private Limited, Quintiles Phase One Clinical Trials India Private Limited, Iqvia Analytics Services Private Limited, Q Squared Solutions (India) Private Limited.
The total paid-up capital of all companies where Nilanjan Sinha holds active positions is ₹479,159,790.00.
Nilanjan Sinha was previously associated with 2 companies, 159 Technology Solutions Private Limited, Aecio It Solutions India Private Limited.